Copyright Reports & Markets. All rights reserved.

Global Human Factor VIII Concentrate Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Human Factor VIII Concentrate Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Blood Extraction
    • 1.3.3 Recombine
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Human Factor VIII Concentrate Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Congenital Coagulation Factor VIII Deficiency
    • 1.4.3 Acquired Factor VIII Deficiency
    • 1.4.4 Von Willebrand's Disease
  • 1.5 Global Human Factor VIII Concentrate Market Size & Forecast
    • 1.5.1 Global Human Factor VIII Concentrate Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Human Factor VIII Concentrate Sales Quantity (2021-2032)
    • 1.5.3 Global Human Factor VIII Concentrate Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Pfizer
    • 2.1.1 Pfizer Details
    • 2.1.2 Pfizer Major Business
    • 2.1.3 Pfizer Human Factor VIII Concentrate Product and Services
    • 2.1.4 Pfizer Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Pfizer Recent Developments/Updates
  • 2.2 Novo Nordisk A/S
    • 2.2.1 Novo Nordisk A/S Details
    • 2.2.2 Novo Nordisk A/S Major Business
    • 2.2.3 Novo Nordisk A/S Human Factor VIII Concentrate Product and Services
    • 2.2.4 Novo Nordisk A/S Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Novo Nordisk A/S Recent Developments/Updates
  • 2.3 Shire (Baxter)
    • 2.3.1 Shire (Baxter) Details
    • 2.3.2 Shire (Baxter) Major Business
    • 2.3.3 Shire (Baxter) Human Factor VIII Concentrate Product and Services
    • 2.3.4 Shire (Baxter) Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Shire (Baxter) Recent Developments/Updates
  • 2.4 Bayer
    • 2.4.1 Bayer Details
    • 2.4.2 Bayer Major Business
    • 2.4.3 Bayer Human Factor VIII Concentrate Product and Services
    • 2.4.4 Bayer Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Bayer Recent Developments/Updates
  • 2.5 GC Pharma
    • 2.5.1 GC Pharma Details
    • 2.5.2 GC Pharma Major Business
    • 2.5.3 GC Pharma Human Factor VIII Concentrate Product and Services
    • 2.5.4 GC Pharma Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 GC Pharma Recent Developments/Updates
  • 2.6 Shanghai Raas Corp
    • 2.6.1 Shanghai Raas Corp Details
    • 2.6.2 Shanghai Raas Corp Major Business
    • 2.6.3 Shanghai Raas Corp Human Factor VIII Concentrate Product and Services
    • 2.6.4 Shanghai Raas Corp Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Shanghai Raas Corp Recent Developments/Updates
  • 2.7 Hualan Biological
    • 2.7.1 Hualan Biological Details
    • 2.7.2 Hualan Biological Major Business
    • 2.7.3 Hualan Biological Human Factor VIII Concentrate Product and Services
    • 2.7.4 Hualan Biological Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Hualan Biological Recent Developments/Updates
  • 2.8 Shandong Taibang Biological Products
    • 2.8.1 Shandong Taibang Biological Products Details
    • 2.8.2 Shandong Taibang Biological Products Major Business
    • 2.8.3 Shandong Taibang Biological Products Human Factor VIII Concentrate Product and Services
    • 2.8.4 Shandong Taibang Biological Products Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Shandong Taibang Biological Products Recent Developments/Updates
  • 2.9 Shanghai Xinxing Medicine
    • 2.9.1 Shanghai Xinxing Medicine Details
    • 2.9.2 Shanghai Xinxing Medicine Major Business
    • 2.9.3 Shanghai Xinxing Medicine Human Factor VIII Concentrate Product and Services
    • 2.9.4 Shanghai Xinxing Medicine Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Shanghai Xinxing Medicine Recent Developments/Updates
  • 2.10 SinoCell Tech
    • 2.10.1 SinoCell Tech Details
    • 2.10.2 SinoCell Tech Major Business
    • 2.10.3 SinoCell Tech Human Factor VIII Concentrate Product and Services
    • 2.10.4 SinoCell Tech Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 SinoCell Tech Recent Developments/Updates
  • 2.11 CSL
    • 2.11.1 CSL Details
    • 2.11.2 CSL Major Business
    • 2.11.3 CSL Human Factor VIII Concentrate Product and Services
    • 2.11.4 CSL Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 CSL Recent Developments/Updates
  • 2.12 Grifols
    • 2.12.1 Grifols Details
    • 2.12.2 Grifols Major Business
    • 2.12.3 Grifols Human Factor VIII Concentrate Product and Services
    • 2.12.4 Grifols Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Grifols Recent Developments/Updates
  • 2.13 Biogen
    • 2.13.1 Biogen Details
    • 2.13.2 Biogen Major Business
    • 2.13.3 Biogen Human Factor VIII Concentrate Product and Services
    • 2.13.4 Biogen Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Biogen Recent Developments/Updates
  • 2.14 Octapharma
    • 2.14.1 Octapharma Details
    • 2.14.2 Octapharma Major Business
    • 2.14.3 Octapharma Human Factor VIII Concentrate Product and Services
    • 2.14.4 Octapharma Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Octapharma Recent Developments/Updates
  • 2.15 NovoNordisk
    • 2.15.1 NovoNordisk Details
    • 2.15.2 NovoNordisk Major Business
    • 2.15.3 NovoNordisk Human Factor VIII Concentrate Product and Services
    • 2.15.4 NovoNordisk Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 NovoNordisk Recent Developments/Updates

3 Competitive Environment: Human Factor VIII Concentrate by Manufacturer

  • 3.1 Global Human Factor VIII Concentrate Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Human Factor VIII Concentrate Revenue by Manufacturer (2021-2026)
  • 3.3 Global Human Factor VIII Concentrate Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Human Factor VIII Concentrate by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Human Factor VIII Concentrate Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Human Factor VIII Concentrate Manufacturer Market Share in 2025
  • 3.5 Human Factor VIII Concentrate Market: Overall Company Footprint Analysis
    • 3.5.1 Human Factor VIII Concentrate Market: Region Footprint
    • 3.5.2 Human Factor VIII Concentrate Market: Company Product Type Footprint
    • 3.5.3 Human Factor VIII Concentrate Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Human Factor VIII Concentrate Market Size by Region
    • 4.1.1 Global Human Factor VIII Concentrate Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Human Factor VIII Concentrate Consumption Value by Region (2021-2032)
    • 4.1.3 Global Human Factor VIII Concentrate Average Price by Region (2021-2032)
  • 4.2 North America Human Factor VIII Concentrate Consumption Value (2021-2032)
  • 4.3 Europe Human Factor VIII Concentrate Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Human Factor VIII Concentrate Consumption Value (2021-2032)
  • 4.5 South America Human Factor VIII Concentrate Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Human Factor VIII Concentrate Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Human Factor VIII Concentrate Sales Quantity by Type (2021-2032)
  • 5.2 Global Human Factor VIII Concentrate Consumption Value by Type (2021-2032)
  • 5.3 Global Human Factor VIII Concentrate Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Human Factor VIII Concentrate Sales Quantity by Application (2021-2032)
  • 6.2 Global Human Factor VIII Concentrate Consumption Value by Application (2021-2032)
  • 6.3 Global Human Factor VIII Concentrate Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Human Factor VIII Concentrate Sales Quantity by Type (2021-2032)
  • 7.2 North America Human Factor VIII Concentrate Sales Quantity by Application (2021-2032)
  • 7.3 North America Human Factor VIII Concentrate Market Size by Country
    • 7.3.1 North America Human Factor VIII Concentrate Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Human Factor VIII Concentrate Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Human Factor VIII Concentrate Sales Quantity by Type (2021-2032)
  • 8.2 Europe Human Factor VIII Concentrate Sales Quantity by Application (2021-2032)
  • 8.3 Europe Human Factor VIII Concentrate Market Size by Country
    • 8.3.1 Europe Human Factor VIII Concentrate Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Human Factor VIII Concentrate Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Human Factor VIII Concentrate Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Human Factor VIII Concentrate Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Human Factor VIII Concentrate Market Size by Region
    • 9.3.1 Asia-Pacific Human Factor VIII Concentrate Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Human Factor VIII Concentrate Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Human Factor VIII Concentrate Sales Quantity by Type (2021-2032)
  • 10.2 South America Human Factor VIII Concentrate Sales Quantity by Application (2021-2032)
  • 10.3 South America Human Factor VIII Concentrate Market Size by Country
    • 10.3.1 South America Human Factor VIII Concentrate Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Human Factor VIII Concentrate Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Human Factor VIII Concentrate Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Human Factor VIII Concentrate Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Human Factor VIII Concentrate Market Size by Country
    • 11.3.1 Middle East & Africa Human Factor VIII Concentrate Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Human Factor VIII Concentrate Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Human Factor VIII Concentrate Market Drivers
  • 12.2 Human Factor VIII Concentrate Market Restraints
  • 12.3 Human Factor VIII Concentrate Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Human Factor VIII Concentrate and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Human Factor VIII Concentrate
  • 13.3 Human Factor VIII Concentrate Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Human Factor VIII Concentrate Typical Distributors
  • 14.3 Human Factor VIII Concentrate Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Human Factor VIII Concentrate market size was valued at US$ 212 million in 2025 and is forecast to a readjusted size of US$ 276 million by 2032 with a CAGR of 3.9% during review period.
    Complementary therapy for prevention and treatment of hemophilia A acquired coagulation factor Ⅷ deficiency and von Willebrand"s disease
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Human Factor VIII Concentrate market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Human Factor VIII Concentrate market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Human Factor VIII Concentrate market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Human Factor VIII Concentrate market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Human Factor VIII Concentrate market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Human Factor VIII Concentrate
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Human Factor VIII Concentrate market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Novo Nordisk A/S, Shire (Baxter), Bayer, GC Pharma, Shanghai Raas Corp, Hualan Biological, Shandong Taibang Biological Products, Shanghai Xinxing Medicine, SinoCell Tech, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Human Factor VIII Concentrate market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Blood Extraction
    Recombine
    Market segment by Application
    Congenital Coagulation Factor VIII Deficiency
    Acquired Factor VIII Deficiency
    Von Willebrand's Disease
    Major players covered
    Pfizer
    Novo Nordisk A/S
    Shire (Baxter)
    Bayer
    GC Pharma
    Shanghai Raas Corp
    Hualan Biological
    Shandong Taibang Biological Products
    Shanghai Xinxing Medicine
    SinoCell Tech
    CSL
    Grifols
    Biogen
    Octapharma
    NovoNordisk
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Human Factor VIII Concentrate product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Human Factor VIII Concentrate, with price, sales quantity, revenue, and global market share of Human Factor VIII Concentrate from 2021 to 2026.
    Chapter 3, the Human Factor VIII Concentrate competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Human Factor VIII Concentrate breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Human Factor VIII Concentrate market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Human Factor VIII Concentrate.
    Chapter 14 and 15, to describe Human Factor VIII Concentrate sales channel, distributors, customers, research findings and conclusion.

    Buy now